| Quality baseline 50 → 89 Strong |
| +16 | Public product-page COAs and test links for sampled products: sampled magnesium glycinate, spermidine, fadogia, TUDCA, and magnesium L-threonate pages each exposed Certificate of Analysis and/or third-party test-report links. This is not a single batch-lookup portal, so I awarded the low/mid end of the public-COA range: +16 rather than +20. 2, 4, 5, 7, 8, 10, 11, 13, 15 Current website and 2024-2026 COA documents; full weight. · full weight |
| +11 | Third-party independent testing disclosed and evidenced in sampled lab documents. The company claims all products are third-party tested; sampled PDFs include external assay reports and COAs prepared for Double Wood LLC. 2, 3, 5, 6, 8, 9, 11, 12, 14, 15 Current site plus 2024-2026 documents; full weight. · full weight |
| +8 | ISO/IEC 17025-accredited testing evidence. Multiple third-party assay PDFs list ISO/IEC 17025:2017 accreditation by PJLA, but this appears concentrated in a specific outside lab rather than a brand-owned accredited lab program, so I used the low end of the +8 to +12 range. 6, 9, 12, 14, 15 2024-2026 lab reports; full weight. · full weight |
| +5 | Heavy-metal testing disclosed and shown in sampled COAs for arsenic, cadmium, lead, and mercury, with methods such as ICP/ICP-MS and limits/results shown on product COAs. 4, 5, 7, 8, 10, 11, 13, 15 2024-2026 COAs and current product pages; full weight. · full weight |
| +5 | Microbiological testing disclosed and shown in sampled COAs, including total plate count, yeast/mold, coliform, E. coli, Salmonella, and Staphylococcus aureus on several sampled documents. 5, 8, 11, 15 2024-2026 COAs; full weight. · full weight |
| −6 | Mixed independent quality report card: ConsumerLab’s public Double Wood page says 6 products were tested, 4 were Approved for quality, and 2 were Not Approved. Pattern calculation: 2/6 not approved = 33% of tested sample; because details are paywalled and the sample is limited, I applied a modest -6 rather than a severe quality-failure penalty. 16 Current public ConsumerLab brand page; full weight. · full weight |
| — | Not scored No complete line-wide audit was possible. ConsumerLab’s product-specific pass/fail details are paywalled, so the -6 adjustment is based only on the public brand report card. I also did not verify every active SKU’s current lot-specific COA. |
| Formulation baseline 50 → 68 Mixed |
| +10 | Effective dosing across sampled products: sampled products with reasonably evidence-aligned servings included L-theanine 200 mg, Magtein magnesium L-threonate 2 g/serving, TUDCA 500 mg/day, spermidine 10 mg/serving, and vitamin D3/K2 drops. Pattern calculation: about 5 of 8 reviewed products had dosing that clearly matched or plausibly tracked common study/market dosing, so I awarded the low end of the +10 to +15 majority-of-line range. 7, 13, 15, 24, 25 Current product pages and 2025 reviews; full weight. · full weight |
| +8 | Bioavailability technology and premium forms in sampled products: Magtein magnesium L-threonate, magnesium bisglycinate/glycinate, synthetic non-animal TUDCA, and disclosed spermidine trihydrochloride provide stronger ingredient-form signals than generic commodity forms. Not line-wide enough for the high end. 4, 7, 13, 15 Current product pages and 2024-2026 COAs; full weight. · full weight |
| +5 | Branded/premium ingredient signal: magnesium L-threonate product is labeled as Magtein, a patented clinically studied ingredient form. Because this signal is not demonstrated across most of the catalog, I awarded a partial +5 rather than +8. 15, 24 Current product page and 2025 review; full weight. · full weight |
| +6 | Mostly single-ingredient, non-proprietary approach. Official and editorial sources describe Double Wood as emphasizing single ingredients and avoiding proprietary-blend style stacking, making ingredient amounts easier to evaluate. 1, 24, 25 Current brand page and 2025 reviews; full weight. · full weight |
| +3 | Minimal inactive ingredients in sampled COAs: examples include simple capsule/filler systems such as HPMC/hypromellose, rice flour, microcrystalline cellulose, and stearate. Awarded +3 because this is observed in sampled documents but not proven line-wide. 5, 8, 11 2024-2026 COAs; full weight. · full weight |
| −8 | Claims without strong evidence or overstated marketing in parts of the line. Healthline states some claims are overstated and some ingredients have limited evidence; FDA’s 2020 warning letter found hangover/intoxication claims for Dycetin created unapproved-drug issues; and a 2026 law-firm investigation alleges unsupported GLP-1 support/weight claims. Because the 2026 item is only an investigation and the FDA letter is older, I used a mid penalty, not the maximum. 17, 24, 30 Mixed timing: 2026 investigation full weight, 2025 review full weight, 2020 FDA letter 50% historical context; blended penalty. · full weight |
| −6 | Limited human-evidence concern for some niche botanicals/men’s-health products. Fadogia product marketing includes testosterone, athletic performance, libido, fertility, and immune claims, while broader editorial review notes limited evidence for some ingredients in the line. Pattern is emerging, not proven line-wide, so I applied a partial -6. 10, 24 Current product page and 2025 review; full weight. · full weight |
| — | Not scored No comprehensive SKU-by-SKU clinical-dose audit was completed. Several product claims depend on ingredient-level literature that varies in quality, and I did not access paywalled ConsumerLab product-level details. |
| Transparency baseline 50 → 89 Strong |
| +21 | Public COA/test accessibility on product pages. Unlike brands that only say 'tested,' sampled Double Wood pages link COAs and/or third-party reports directly from the product page. Because this is product-page access rather than a centralized batch lookup portal, I awarded +21 instead of the full +25 public-portal maximum. 4, 5, 7, 8, 10, 11, 13, 14, 15 Current website and 2024-2026 documents; full weight. · full weight |
| +10 | Third-party testing disclosed with lab details. Double Wood says every supplement is third-party tested and sampled reports identify outside labs, methods, dates, lot numbers, and in several cases ISO/IEC 17025 accreditation. 2, 3, 6, 9, 12, 14, 15 Current website and 2024-2026 reports; full weight. · full weight |
| +12 | Test results published regularly/at point of sale. Product pages contain COA/test links and sometimes explanatory testing copy, but coverage was sampled rather than confirmed for every SKU, so I used +12 rather than the top +18. 4, 7, 10, 13, 15, 24 Current product pages; full weight. · full weight |
| +7 | Basic ownership/entity and management disclosure. Official About page names CEO Eric Wenke and founders Reese and Evan Wood; BBB lists Double Wood LLC, addresses, entity type, alternate name, and management contacts. This is basic-to-good disclosure, not full parent-company disclosure. 1, 21, 26 Current official/BBB/LinkedIn pages; full weight. · full weight |
| +6 | Manufacturing and location disclosure. Product pages state manufactured in an FDA-registered cGMP facility in the USA from globally sourced materials, and BBB/LinkedIn list Pennsylvania business locations. Facility names and complete supply chain are not disclosed, so this stays at +6. 4, 7, 13, 15, 21, 26 Current pages; full weight. · full weight |
| −5 | Ownership/parent-company ambiguity after private-equity transactions. Public deal sources report Boyne acquired a majority interest in 2021 and later sold Double Wood to Gryphon Investors in March 2026, while the official About page and BBB profile emphasize management/founders and do not clearly reconcile that parent-ownership chain. Small penalty because ownership is findable, but not clearly surfaced by the brand. 1, 21, 28, 29 2026 transaction source is within 2 years; full weight. · full weight |
| −5 | Emerging subscription/autoship transparency complaints. BBB shows recent billing complaints including disputed auto-refill/subscription issues, but the volume is limited relative to the business and BBB also shows company responses. Pattern calculation: 2 billing complaints among 7 BBB complaints in 3 years plus Trustpilot mentions = emerging, not systematic; applying about 25-30% of a -18 subscription-trap penalty. 22, 23 2024-2026 complaints; full weight. · full weight |
| −7 | Marketing claims challenged by regulators/investigators. FDA’s 2020 warning letter cited unapproved-drug hangover/intoxication claims, and a 2026 law-firm investigation alleges unsupported GLP-1 support/weight-management marketing. Because one source is an old resolved regulatory letter and the other is only an investigation, I applied a moderate transparency penalty. 17, 18, 30 2020 FDA item discounted as 5-10 years old; 2026 investigation full weight; blended. · full weight |
| — | Not scored I did not verify every SKU for current lot-specific COA availability. I also could not confirm from an official Double Wood or Gryphon page whether the March 2026 PE transaction is fully closed and reflected in current ownership records. |
| Safety baseline 90 → 70 Adequate |
| −15 | FDA warning letter for Dycetin hangover/intoxication claims. FDA issued a July 23, 2020 warning letter stating claims established the product as an unapproved new drug; FDA’s July 29, 2020 update included Double Wood LLC among companies warned over illegal hangover-product claims. Severity selected: -30 for unapproved-drug/disease-style claims; temporal discount: 5-10 years old = 50%; final -15. 17, 18 July 2020; 5-10 years old as of 2026-06-14; 50% temporal weight applied. · 50% weight |
| −5 | California Proposition 65 60-day notice alleging unwarned lead exposure from Double Wood Supplements Maca Root. This is a notice/allegation, not a final judgment in the reviewed sources. Safety exception applies even though it appears product-specific; selected low -5 due to single product, Prop 65 context, and lack of adjudicated finding. 19, 20 Filed July 5, 2024; within 2 years of scoring date; full weight. · full weight |
| — | Not scored I did not access FDA inspectional 483 records through FOIA or paid regulatory databases. I also did not find a final court outcome for the Prop 65 notice in the reviewed sources. |
| Value baseline 50 → 72 Adequate |
| +14 | Fair-to-affordable price positioning for a third-party-tested brand. Healthline describes Double Wood as affordable and worth considering for shoppers who want supplements that do not break the bank; product-page examples show mid-tier pricing such as $19.95 magnesium glycinate and $30.95 Magtein magnesium L-threonate. Awarded +14 for fair/below-premium pricing with testing documentation. 4, 15, 24, 25 Current product pages and 2025 reviews; full weight. · full weight |
| +10 | Price justified by testing transparency. The brand is not the cheapest possible option, but public COAs, third-party testing, and ConsumerLab’s 4-of-6 approved public result support better-than-generic value. Awarded +10 rather than +15 because 2 of 6 ConsumerLab-tested products were not approved and NSF/USP certifications are absent. 2, 4, 5, 16, 24 Current pages and 2024-2026 tests; full weight. · full weight |
| +6 | Free shipping and 30-day money-back guarantee. Medical News Today reports free U.S. shipping and a 30-day money-back guarantee on the first bottle/multipacks; these are modest value positives. 25 2025 review; full weight. · full weight |
| +3 | Bulk/multi-pack discounts visible on sampled product pages. Awarded the low end because discount generosity varies and was not audited line-wide. 10, 13, 15 Current product pages; full weight. · full weight |
| −6 | Serving-size/value friction in some products. Magnesium L-threonate requires 4 capsules per 2 g serving and the MNT tester criticized serving size/cost; magnesium glycinate provides 60 mg elemental magnesium per capsule despite 400 mg magnesium glycinate front-end positioning. Pattern calculation: 2 of 8 sampled products with notable serving-size friction = 25%; applying about 50% of a -12 small-serving penalty = -6. 4, 15, 25 Current pages and 2025 review; full weight. · full weight |
| −5 | Subscription/autoship complaints can create perceived value loss. BBB and Trustpilot include recent complaints about auto-refill, delivery, refund, or subscription handling. Pattern is limited/emerging rather than systematic, so -5 rather than -12 to -18. 22, 23 2024-2026 complaints; full weight. · full weight |
| — | Not scored No full market basket audit was completed. Pricing changes frequently, and I sampled representative products rather than every SKU and every competitor. |
| Sentiment baseline 60 → 64 Mixed |
| +8 | Current BBB A+ rating and accreditation. BBB lists Double Wood as accredited since August 12, 2025 with an A+ rating. Awarded +8, the low end of the BBB-positive range, because accreditation is recent and complaint history still exists. 21 Current BBB profile; full weight. · full weight |
| +5 | Documented responsiveness to complaints. BBB complaint pages show company responses to several complaints, and Trustpilot shows company replies to recent reviews. Awarded +5 because responses are visible but not uniformly praised by consumers. 22, 23 2024-2026 complaint/review responses; full weight. · full weight |
| +7 | Positive customer/editorial sentiment around quality, price, and COA access. Healthline reports satisfied customers praise quality ingredients, affordable prices, and public COAs; product pages show strong internal review ratings for products such as Magtein, though own-site reviews are weighted cautiously. 15, 24, 40 Current product page, 2025 review, 2025 Reddit thread; full weight. · full weight |
| −7 | Mixed service/shipping/refund sentiment. Healthline calls reviews mixed; BBB shows 7 complaints in the last 3 years; Trustpilot includes recent delivery/refund/customer-service complaints. Pattern is mixed, not overwhelmingly negative, so -7 rather than -12 to -18. 22, 23, 24 2024-2026 complaints and 2025 review; full weight. · full weight |
| −5 | Community skepticism on Reddit/forums about testing depth, review incentives, and perceived effectiveness. Multiple threads raise concerns, but they are anecdotal, sometimes old, and counterbalanced by positive/defensive community comments; applying a modest -5. 37, 38, 39, 40 Mixed: 2022-2025 threads; mainly 2-5 years old or recent; blended full/75% effect represented in modest penalty. · 75% weight |
| −4 | ConsumerLab mixed public report card affects community trust. 4 of 6 products approved is a positive, but 2 Not Approved products create legitimate skepticism. Scored as -4 in social because shoppers see mixed external validation. 16 Current public ConsumerLab page; full weight. · full weight |
| — | Not scored I did not scrape all Amazon reviews, TikTok/Instagram comments, or every Reddit thread. Social scoring is based on representative BBB, Trustpilot, editorial, ConsumerLab, and forum evidence. |